Dihydronicotinamide riboside

  • 2 independent labs in 2 countries
  • Funders: Cornell University and 5 more
  • 3 of 7 findings with company ties
  • Animals2

Outcomes

7

Obesity

downin mice1

1 study
  1. Dihydronicotinamide riboside decreases obesity in mice.

    “NRH mitigates high-fat diet-induced metabolic complications when used as a preventive or as a treatment strategy”

    Animalshigh-fat diet-induced metabolic complications100 mg/(kg*day)

    Therapeutic potential of dihydronicotinamide riboside (NRH) on obesity and glucose intolerance in mice

    Nature communications25 Mar 2026

More on Obesity

Lipid and ceramide metabolism

upin mice1

1 study
  1. Dihydronicotinamide riboside increases lipid and ceramide metabolism in mice.

    “increased hepatic expression of lipid catabolism genes and fat redistribution”

    Animalshigh-fat dietliver100 mg/(kg*day)

    Therapeutic potential of dihydronicotinamide riboside (NRH) on obesity and glucose intolerance in mice

    Nature communications25 Mar 2026

More on Lipid and ceramide metabolism

Glucose tolerance

upin mice1

1 study
  1. Dihydronicotinamide riboside improves glucose tolerance in mice.

    “NRH mitigates high-fat diet-induced metabolic complications when used as a preventive or as a treatment strategy, including improvements in glucose tolerance”

    Animalshigh-fat diet-induced metabolic complications100 mg/(kg*day)

    Therapeutic potential of dihydronicotinamide riboside (NRH) on obesity and glucose intolerance in mice

    Nature communications25 Mar 2026

Ferroptosis

downin mice1

1 study
  1. Dihydronicotinamide riboside inhibits ferroptosis in mice.

    “inhibiting oxidative stress and lipid peroxidation via modulation of ferroptosis-related pathways”

    Animalscochlea

    NRH attenuates age-related hearing loss by suppressing cochlear ferroptosis and cellular senescence via Sirt3 activation

    Free radical biology & medicine25 Feb 2026

More on Ferroptosis

Cellular senescence

downin mice1

1 study
  1. Dihydronicotinamide riboside decreases cellular senescence in mice.

    “inhibiting oxidative stress and lipid peroxidation via modulation of ferroptosis-related pathways, ultimately mitigating cochlear cellular senescence.”

    Animalscochlea

    NRH attenuates age-related hearing loss by suppressing cochlear ferroptosis and cellular senescence via Sirt3 activation

    Free radical biology & medicine25 Feb 2026

More on Cellular senescence

SIRT3

upin mice1

1 study
  1. Dihydronicotinamide riboside activates SIRT3 in mice.

    “NRH activated Sirt3, thereby inhibiting oxidative stress and lipid peroxidation via modulation of ferroptosis-related pathways, ultimately mitigating cochlear cellular senescence.”

    Animalscochlea

    NRH attenuates age-related hearing loss by suppressing cochlear ferroptosis and cellular senescence via Sirt3 activation

    Free radical biology & medicine25 Feb 2026

More on SIRT3

Age-related hearing loss

downin mice1

1 study
  1. Dihydronicotinamide riboside decreases age-related hearing loss in mice.

    “NRH administration ameliorated ARHL in C57BL/6 mice, as evidenced by improved auditory thresholds and elevated cochlear NAD+ levels.”

    Animalsagingcochlea125 mg/kg

    NRH attenuates age-related hearing loss by suppressing cochlear ferroptosis and cellular senescence via Sirt3 activation

    Free radical biology & medicine25 Feb 2026

More on Age-related hearing loss

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 1Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 03 in 12 months